Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerase (PARP), blocks replication of the SARS-CoV-2 human coronavirus <i>in vitro</i>
Nathan E. Stone(Northern Arizona University), Christopher T. French(Northern Arizona University), Ashley Jones(Northern Arizona University), Sierra A. Jaramillo(Northern Arizona University), Adam J. Vazquez(Northern Arizona University), Lora M. Versluis(Northern Arizona University), Haley E. Nunnally(Northern Arizona University), Erik W. Settles(Northern Arizona University), Roxanne Nottingham(Northern Arizona University), Paul Keim(Northern Arizona University), Steen Knudsen(MC2 Therapeutics (Denmark)), Jason W. Sahl(Northern Arizona University), David M. Wagner(Northern Arizona University), Madison Martz(Northern Arizona University), Marlee O. Raniere(Northern Arizona University), Katherine E. Zarn(Northern Arizona University)
Cited by 0
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.2k
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
|Applied and Environmental Microbiology|2009|21.9k
Author Correction: Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|878
Origins of the <i>E. coli</i> Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
|New England Journal of Medicine|2011|833